Lung-Carcinoma-Portalby
Lung-Carcinoma-Portalby

Therapeutic options here are based on EMA drug approvals with deviating approval details clearly marked. Drugs availability may vary in your country.

Experts
The Lung-Carcinoma-Portal is scientifically accompanied by

Prof. Dr. rer. nat. Jutta Kirfel - Head of Molecular Pathology University Hospital Schleswig Holstein

Prof. Dr. rer. nat. Jutta Kirfel

Head of Molecular Pathology
University Hospital Schleswig Holstein

Prof. Dr. med. Sven Perner, FRCPath, IFCAP - Board-certified Pathologist PATHORA Institute for Pathology and Tissue Medicine

Prof. Dr. med. Sven Perner, FRCPath, IFCAP

Board-certified Pathologist
PATHORA Institute for Pathology and Tissue Medicine

Dr. med. Miriam Möller - Senior physician and coordinator Lung Cancer Center Martha-Maria Halle-Dölau Hospital

Dr. med. Miriam Möller

Senior physician and coordinator
Lung Cancer Center
Martha-Maria Halle-Dölau Hospital

Priv.-Doz. Dr. med. Niels Reinmuth - Senior Physician Thoracic Oncology Asklepios Specialist Clinics Munich-Gauting

Priv.-Doz. Dr. med. Niels Reinmuth

Senior Physician Thoracic Oncology
Asklepios Specialist Clinics Munich-Gauting

We use cookies on our website. Some of them are technically necessary, while others help us to improve this website or to provide additional functionalities.